探索患有HER2阳性乳腺癌的患者的治疗挑战 - - 一个单一中心的体验
Ramona Coca1,2, Andrei Moisin3,4, Rafaela Coca1,2
1Clinical Medical Department, Faculty of General Medicine, "Lucian Blaga" University of Sibiu, Str. Lucian Blaga nr. 2A, 550169 Sibiu, Romania.
Life (Basel, Switzerland)
|August 29, 2024
概括
HER2阳性乳腺癌患者从抗HER2疗法中获得显著益处. 这种治疗导致了完全病理反应的高率和疾病缓解或稳定.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 乳腺癌是全球主要的瘤.
- 由EGFR-ERBB2受体突变驱动的HER2过度表达影响疾病的进展和治疗.
- 个性化治疗策略对于治疗乳腺癌至关重要.
研究的目的:
- 在新的乳腺癌病例中评估HER2过度表达.
- 评估HER2状态对疾病自然史的影响.
- 分析基于HER2状态和分期的治疗个性化.
主要方法:
- 这是一项45名 HER2 过度表达乳腺癌患者的观察性研究.
- 甲固定型氨酸嵌入乳腺组织的免疫组织化学染色.
- 在所有疾病阶段进行人口统计,治疗和组织病理学评估.
主要成果:
- 在19名患者 (44%) 观察到完整的病理反应.
- 15名患者 (44%) 出现了残留疾病的病理反应.
- 在抗HER2疗法下,无病间隔 (DFI) 为91% (41名患者).
结论:
- 抗HER2疗法有效地阻断了HER2阳性乳腺癌中的铁氨酸激酶受体.
- 实现了完全病理反应 (44%) 和缓解/稳定疾病 (47%) 的高率.
- 抗HER2治疗在所有治疗阶段都显示出显著的疗效.
更多相关视频
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.6K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K